Xiaohong Wu

AENEAS: A Randomized Phase III Trial of Aumolertinib Versus Gefitinib as First-Line Therapy for Locally Advanced or MetastaticNon–Small-Cell Lung Cancer With <i>EGFR</i> Exon 19 Deletion or L858R Mutations

Shun Lü, Xiaorong Dong, Hong Jian et al. · Journal of Clinical Oncology · 2022 · 253 citations · Full text

The Dual Functions of WLIM1a in Cell Elongation and Secondary Wall Formation in Developing Cotton Fibers

Libo Han, Y.-B. Li, Hengyang Wang et al. · The Plant Cell · 2013 · 225 citations · Full text

Early wheat in China: Results from new studies at Donghuishan in the Hexi Corridor

Rowan K. Flad, Shuicheng Li, Xiaohong Wu et al. · The Holocene · 2010 · 207 citations

Crop Production, Engineering, East Asian Studies +14

Cardiac macrophage migration inhibitory factor inhibits JNK pathway activation and injury during ischemia/reperfusion

Dake Qi, Xiaoyue Hu, Xiaohong Wu et al. · Journal of Clinical Investigation · 2009 · 173 citations · Full text

Cardiac Muscle, Immunology, Cell Death +20

Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non–Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01)

Zhijie Wang, Lin Wu, Baolan Li et al. · Journal of Clinical Oncology · 2022 · 161 citations · Full text